CHEST, in press, May 1996.
WOLFGANG SCHMIDT-NOWARE, M.D.
Pulmary Division, University of New Mexico
The advent of oral appliance therapy and the significance of this study need to be placed in a broad perspective. Of the 8 million men and women in this country age 30 and older with OSA (subject with RDI >or = 15, prevalence from Young,et.al., reference 6), most have relatively mild disease. OA therapy provides an important treatment choice in this group, and may be the preferred initial treatment. Clinicians caring for OSA patients should add OA to their vocabulary and OA therapy to their repertoire.
